These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 436334)

  • 1. Abnormal lymphocyte responses in residents of a town with a cluster of Hodgkin's disease.
    Plouffe JF; Silva J; Schwartz RS; Callen JP; Kane P; Murphy LA; Goldstein IJ; Fekety R
    Clin Exp Immunol; 1979 Feb; 35(2):163-70. PubMed ID: 436334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cluster of Hodgkin's disease in a small community: evidence for environmental factors.
    Schwartz RS; Callen JP; Silva J
    Am J Epidemiol; 1978 Jul; 108(1):19-26. PubMed ID: 685972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of immune response in mice by navy bean lectin.
    Plouffe J; Lofgren R; Silva J; Fekety R; Goldstein I
    J Clin Lab Immunol; 1980 May; 3(3):189-90. PubMed ID: 7420407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
    Land JM; Litwin J; Bigel P; Oberling F; Mayer S
    Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous lymphocyte proliferation and depressed cellular immunity in Hodgkin's disease.
    Shiftan TA; Caviles AP; Mendelsohn J
    Clin Exp Immunol; 1978 Apr; 32(1):144-52. PubMed ID: 668190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte reactivity to phytohaemagglutinin and allogeneic lymphocytes in 32 untreated patients with Hodgkin's disease.
    Lang JM; Oberling F; Bigel P; Mayer S; Waitz R
    Biomedicine; 1974 Sep; 21(9):372-7. PubMed ID: 4281669
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lymphocyte culture in the presence of phytohemagglutinins in Hodgkin's disease].
    Ferrari S; Foggi CM; Serafini NA
    Ann Ist Carlo Forlanini; 1968; 28(3):292-309. PubMed ID: 4903142
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
    Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
    Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired lymphocyte function in untreated Hodgkin's disease.
    Levy R; Kaplan HS
    N Engl J Med; 1974 Jan; 290(4):181-6. PubMed ID: 4203007
    [No Abstract]   [Full Text] [Related]  

  • 10. Spleen lymphocyte populations in patients with Hodgkin's disease--properties of cells with different densities.
    Rocha B; Ferreira AA; Munn G; de Sousa M; Freitas AA
    Clin Exp Immunol; 1982 May; 48(2):300-6. PubMed ID: 7105487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive serum factors and lymphocyte deficiency in Hodgkin's disease.
    Holm G; Angelin B; Björkholm M; Ericsson P; Mellstedt H; Pettersson D
    J Clin Lab Immunol; 1979 Feb; 1(4):269-75. PubMed ID: 501725
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte function in patients with Hodgkin's disease.
    Rühl H; Vogt W; Rühl U
    G Batteriol Virol Immunol; 1975; 68(1-6):3-16. PubMed ID: 128484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing features of the immunology of Hodgkin's disease in children.
    Tan CT; De Sousa M; Good RA
    Cancer Treat Rep; 1982 Apr; 66(4):969-75. PubMed ID: 7074657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of implantation of human fetal thymus on the immunological reactivity in patients with Hodgkin's disease].
    Pekić B; Dujić A; Radojicić B; Radojicić C; Kolasinović N; Martinović N; Susaković N; Radovanović L
    Bilt Hematol Transfuz; 1975; 3(1-2):105-19. PubMed ID: 1225309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cluster of Hodgkin's lymphoma in residents near a non-operational petroleum refinery.
    Dahlgren J; Klein J; Takhar H
    Toxicol Ind Health; 2008 Nov; 24(10):683-92. PubMed ID: 19141572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: "a cluster of Hodgkin's disease in a small community".
    Zack M; Heath CW; Isbister JL; Van Amburg G
    Am J Epidemiol; 1979 May; 109(5):621-2. PubMed ID: 453183
    [No Abstract]   [Full Text] [Related]  

  • 19. Binding of phytohaemagglutinin to serum substances and inhibition of lymphocyte transformation in Hodgkin's disease.
    Amlot PL; Unger A
    Clin Exp Immunol; 1976 Dec; 26(3):520-7. PubMed ID: 1009684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.
    Deshazo RD; Ewel C; Londono S; Metzger Z; Hoffeld JT; Oppenheim JJ
    Clin Exp Immunol; 1981 Nov; 46(2):313-20. PubMed ID: 7337972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.